Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Short-term Investments (2019 - 2025)

Quantum Biopharma's Short-term Investments history spans 7 years, with the latest figure at $459080.0 for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 61.82% to $459080.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $459080.0, a 61.82% decrease, with the full-year FY2025 number at $459080.0, down 61.82% from a year prior.
  • Short-term Investments hit $459080.0 in Q4 2025 for Quantum Biopharma, up from -$462325.0 in the prior quarter.
  • Over the last five years, Short-term Investments for QNTM hit a ceiling of $3.5 million in Q3 2024 and a floor of -$462325.0 in Q3 2025.
  • Historically, Short-term Investments has averaged $807996.5 across 5 years, with a median of $540203.0 in 2022.
  • Biggest five-year swings in Short-term Investments: skyrocketed 11902.6% in 2023 and later crashed 113.26% in 2025.
  • Tracing QNTM's Short-term Investments over 5 years: stood at $158036.0 in 2021, then plummeted by 96.1% to $6162.0 in 2022, then skyrocketed by 11902.6% to $739600.0 in 2023, then surged by 62.57% to $1.2 million in 2024, then plummeted by 61.82% to $459080.0 in 2025.
  • Business Quant data shows Short-term Investments for QNTM at $459080.0 in Q4 2025, -$462325.0 in Q3 2025, and $20868.0 in Q1 2025.